Grifols

Ticker: GRFS

Sector: Biotechnology

Grifols

Grifols SA pays a dividend of $0.34 which represents an annual dividend yield of N/A. The best plasma deals can presently be found at your local Grifolols donation center. Grifols is a global healthcare company that produces essential plasma-derived medicines. Grifols, S.A. (GRFS) Earnings Report | Seeking Alpha Skip to content Home Analysis News Market Data Investing Groups Explore Investing groups Explore investing groups Explore Portfolio Find & Compare Top Stocks Top ETFs and ETFs. Grifols Dunn Ave is a leading digital health platform that offers comprehensive healthcare solutions to meet all your needs. The event was sponsored by Biomat USA, a prominent plasma donation center. Blood Transfusion Devices Market Is Booming Worldwide 2023-2030. Blood Translusion Devices market is booming worldwide. Grifols S.A. announced a comprehensive plan to save money and resources that will result in 2,000 U.S. blood transfusion devices. Grifols is part of the Grifol Group, Barcelona, Spain. Grifols Plasma has 2.1 star rating based on 194 customer reviews and ranks 242 of 2424 among companies in Hospitals, Clinics and Medical Centers category. 5% of users would likely recommend Grifol Plasma to a friend or colleague. Spanish drugmaker Grifols reported a profit of 52 million euros ($57.69 million) as revenues grew 8%. The firm saw 8.8% constant currency sales growth in the second quarter.